Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2026 16:05 ET | Source: Insight Molecular Diagnostics Inc.

iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress

Multiple events and presentations will highlight potential benefits of in-house transplanted-organ-rejection testing, and of GraftAssure technology specificallyMajor transplantation conference in...
June 09, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, June 09, 2026 (GLOBE NEWSWIRE) -- Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight The...
June 08, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight

New York, USA, June 08, 2026 (GLOBE NEWSWIRE) -- Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as...
June 08, 2026 08:43 ET | Source: Alkeus Pharmaceuticals

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Alkeus Pharmaceuticals announces first patient dosed in pivotal global Phase 3 NORTHSTAR Study of oral gildeuretinol in Stargardt disease.
June 08, 2026 08:00 ET | Source: Vaxart, Inc.

Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY

Mails Letter to Shareholders Detailing Strength of the Board’s Nominees and Momentum in Advancing Vaxart’s Value Creation Strategy Reinforces that the Dissident’s Nominees Have No Relevant...
June 08, 2026 06:17 ET | Source: Bleichmar Fonti & Auld

$PLNT Securities Notice: BFA Law Notifies Planet Fitness Investors of the Pending Securities Fraud Investigation to Recover Losses – Act Now if You Lost Money

BFA Law Notifies Planet Fitness Investors of the Pending Securities Fraud Investigation to Recover Losses – Act Now if You Lost Money
June 08, 2026 04:00 ET | Source: Alvotech

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...
June 08, 2026 04:00 ET | Source: Alvotech

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 8, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
June 05, 2026 08:29 ET | Source: Moleculin Biotech, Inc.

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transplant-bridging potential, biomarker-agnostic use and reduced cardiotoxicity as key drivers Parallel...
June 05, 2026 06:36 ET | Source: Bleichmar Fonti & Auld

$PLNT Stock Notification: Lose Money on Your Planet Fitness Investment? Contact BFA Law about its Ongoing Securities Fraud Investigation

Lose Money on Your Planet Fitness Investment? Contact BFA Law about its Ongoing Securities Fraud Investigation